TY - JOUR T1 - Validation of molecular clock inferred HIV infection ages: evidence for accurate estimation of infection dates JF - medRxiv DO - 10.1101/2020.12.11.20247601 SP - 2020.12.11.20247601 AU - E. G. Kostaki AU - S. Limnaios AU - S. Roussos AU - M. Psichogiou AU - G.K. Nikolopoulos AU - S-R. Friedman AU - A. Antoniadou AU - M. Chini AU - A. Hatzakis AU - V. Sypsa AU - G. Magiorkinis AU - C. Seguin-Devaux AU - D. Paraskevis Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/11/2020.12.11.20247601.abstract N2 - Improving HIV diagnosis, access to care and effective antiretroviral treatment provides our global strategy to reduce HIV incidence. To reach this goal we need to increase our knowledge about local epidemics. HIV infection dates would be an important information towards this goal, but they are largely unknown. To date, methods to estimate the dates of HIV infection are based mainly on laboratory or molecular methods. Our aim was to validate molecular clock inferred infection dates that were estimated by analysing sequences from 145 people living with HIV (PLHIV) with known transmission dates (clinically estimated infection dates). All HIV sequences were obtained by Sanger sequencing and were previously found to belong to well-established molecular transmission clusters (MTCs). Our analysis showed that the molecular clock inferred infection dates were correlated with the clinically estimated ones (Spearman’s Correlation coefficient = 0.93, p<0.001) and that there was an agreement between them (Lin’s concordance correlation coefficient = 0.92, p<0.001). For most cases (61.4%), the molecular clock inferred preceded the clinically estimated infection dates. The median difference between clinically and molecularly estimated dates of infection was of 0.18 (IQR: -0.21, 0.89) years. The lowest differences were identified in people who inject drugs of our study population. Our study shows that the estimated time to more recent common ancestor (tMRCA) of nodes within clusters provides a reliable approximation of HIV infections for PLHIV infected within MTCs. Next-generation sequencing data and molecular clock estimates based on heterochronous sequences provide, probably, more reliable methods for inferring infection dates. However, since these data are not available in most of the HIV clinical laboratories, our approach, under specific conditions, can provide a reliable estimation of HIV infection dates and can be used for HIV public health interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study has been supported in part by the following grants: i) ARISTOTLE program was implemented under National Strategic Reference Framework 2007-2013 (MIS 365008) and was cofunded by the European Social Fund, national resources and the Hellenic Scientific Society for the Study of AIDS and STDs, ii) TRIP program was supported by the United States National Institute on Drug Abuse (NIDA) (DP1 DA034989), iii) data from Luxembourg were collected in the context of studies supported by grants from the Ministry of Health of Luxembourg (HIV-MSAN) and iv) 2018 Asklepios Gilead Hellas Grants Programme.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committee of the Medical School, National and Kapodistrian University of Athens.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe will share our data upon reasonable request. ER -